Convertible Bond Offering - Final Terms

RNS Number : 0242H
Primary Health Properties PLC
13 May 2014
 



 

News Release

 

 

NOT FOR DISTRIBUTION IN OR TO THE U.S., CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

Primary Health Properties PLC Convertible Bond Offering

 

Primary Health Properties PLC (the "Company" or "PHP" and together with its subsidiaries, the "Group") today announces the final terms of its offering (the "Offering") of £75m of senior, unsecured guaranteed Convertible Bonds due 2019 (the "Bonds"). The Bonds will be issued by PHP Finance (Jersey) Limited (the "Issuer"), a wholly-owned subsidiary of the Company incorporated in Jersey, and will be guaranteed by the Company. The Bonds will be senior and unsecured obligations of the Issuer and will be subject to a negative pledge. The Company has also granted ISM Capital LLP (the "Sole Global Coordinator") an option to procure subscribers for an additional £7.5m of Bonds at its election within 30 days of the Settlement Date.  The Offering is not underwritten.

 

The Bonds will mature in May 2019, will be issued at par and will carry a coupon of 4.25% per annum payable semi-annually in arrear.  Subject to certain conditions, the Bonds will be convertible into preference shares of the Issuer which will be automatically and mandatorily exchangeable into fully paid ordinary shares of the Company (the "Shares"). The initial conversion price has been set at 390 pence per Share, representing a premium of 16.0% above the volume weighted average price of the Company's Shares from launch to pricing. Under the terms of the Bonds, the Company will have the right to settle any conversion rights entirely in Shares, in cash or with a combination of Shares and cash.

 

Settlement is expected to take place on or about 20 May 2014 (the "Settlement Date").

 

ISM Capital LLP is acting as Sole Global Coordinator and Bookrunner in relation to the Offering,  The Royal Bank of Scotland plc is acting as Co-Bookrunner in relation to the Offering and Peel Hunt LLP is acting as Co-Lead Manager and corporate broker to the Company (together the "Managers").

 

 

Further details:

 

Primary Health Properties PLC

Tel: 020 7451 7050

 

Harry Hyman, Managing Director

 

ISM Capital LLP

Tel: 020 7938 8984

 

Christopher Thurn, Head of Capital Markets

Michael Coakley, Partner

 

Nexus TradeCo Limited

Tel: 020 7104 5599

 

Phil Holland

 

Bell Pottinger

Tel: 020 7861 3925

 

David Rydell/ Victoria Geoghegan

 

Peel Hunt LLP

Tel: 020 7418 8900

 

Andy Crossley / Capel Irwin/Hugh Preston

The Royal Bank of Scotland plc

Tel: 020 7085 5000

 

Rupert Snuggs/Jonathan Feast

 

 

About Primary Health Properties PLC

 

Primary Health Properties PLC (LSE: PHP) a UK Real Estate Investment Trust ("REIT") and the UK's leading investor in modern primary healthcare premises.

 

PHP was listed on AIM in 1996 and moved to the Official List of the London Stock Exchange on 5 November 1998.  As at 10 April 2014, PHP owned some 262 assets with a total book value of £981 million.  PHPs contracted rent roll as at 31 March 2014 totalled £59.2 million (including assets under development) and its portfolio had a Weighted Average Unexpired Lease Term of 16 years.

 

www.phpgroup.co.uk

 

 

DISCLAIMER

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The information in this announcement is subject to change.

 

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes, should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement does not constitute or form part of an offer to sell securities or the solicitation of any offer to subscribe for or otherwise buy any securities to any person in the United States, Australia, Canada, Japan, South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in this announcement have not been and will not be registered in the United States under the US Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States unless registered under the Securities Act or offered in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, South Africa, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, South Africa, Canada or Japan. There will be no public offer of the securities in the United States, Australia, Canada, Japan or South Africa.

 

The Offering is addressed to, and directed in member states of the European Economic Area which have implemented the Prospectus Directive (the "Prospectus Directive") at, persons who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (directive 2003/71/EC, as amended) ("qualified investors"). In addition, in the United Kingdom, the Offering is directed only at qualified investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") and qualified investors falling within Article 49(2)(a) to (d) of the Order, and (ii) to whom it may otherwise lawfully be communicated under the Order (all such persons together being referred to as "relevant persons"). This communication must not be acted on or relied on by persons who are not relevant persons in the United Kingdom or qualified investors as the case may be. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons or qualified investors as the case may be.

 

Each of the Managers, each of which is authorised and regulated by the Financial Conduct Authority, is acting exclusively for the Company and no one else in connection with the Offering and will not be responsible to any other person for providing the protections afforded to clients of such Manager respectively or for providing advice in relation to the Offering, the Bonds or any other transaction, matter or arrangement referred to in this announcement.

 

Each of the Company, the Issuer, the Managers and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any statement contained in this announcement whether as a result of new information, future developments or otherwise.

 

Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing all of the amount invested. Persons considering making such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation concerning the Bonds. The value of the Bonds can decrease as well as increase. Potential investors should consult a professional advisor as to the suitability of the Bonds for the person concerned.

 

In connection with the Offering, the Managers and any of their affiliates, acting as investors for their own accounts, may subscribe for or purchase securities and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such securities and any other securities of the Company or the Issuer or related investments in connection with the Bonds or the Company, the Issuer or otherwise. Accordingly, references to the securities being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by, the Managers and any of their respective affiliates acting as investors for their own accounts. The Managers do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

None of the Managers, or any of their respective directors, officers, employees, affiliates, advisers or agents accepts any responsibility, duty or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, the Issuer, its other subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

Stabilisation/FCA.  ISM Capital LLP is the Stabilisation Manager.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKSDFFELEFF
UK 100

Latest directors dealings